BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19408578)

  • 21. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
    Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE
    Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
    Choi WH; Yoo IeR; O JH; Kim TJ; Lee KY; Kim YK
    Technol Health Care; 2015; 23 Suppl 2():S311-8. PubMed ID: 26410497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.
    Izuishi K; Yamamoto Y; Sano T; Takebayashi R; Nishiyama Y; Mori H; Masaki T; Morishita A; Suzuki Y
    J Gastrointest Surg; 2012 Feb; 16(2):394-400. PubMed ID: 22065316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
    Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
    Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlations with (18)FDG PET scan patterns in solid pseudopapillary tumors of the pancreas: still a surgical enigma?
    Kang CM; Cho A; Kim H; Chung YE; Hwang HK; Choi SH; Lee WJ
    Pancreatology; 2014; 14(6):515-23. PubMed ID: 25256437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological correlates of FDG uptake in non-small cell lung cancer.
    de Geus-Oei LF; van Krieken JH; Aliredjo RP; Krabbe PF; Frielink C; Verhagen AF; Boerman OC; Oyen WJ
    Lung Cancer; 2007 Jan; 55(1):79-87. PubMed ID: 17046099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
    Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
    J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.
    Watanabe Y; Suefuji H; Hirose Y; Kaida H; Suzuki G; Uozumi J; Ogo E; Miura M; Takasu K; Miyazaki K; Nakahara K; Ishibashi M; Okamura T; Ohshima K; Hayabuchi N
    Int J Hematol; 2013 Jan; 97(1):43-9. PubMed ID: 23212465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False positive 18F-FDG PET in an ischial chondroblastoma; an analysis of glucose transporter 1 and hexokinase II expression.
    Hamada K; Ueda T; Tomita Y; Higuchi I; Inoue A; Tamai N; Myoui A; Aozasa K; Yoshikawa H; Hatazawa J
    Skeletal Radiol; 2006 May; 35(5):306-10. PubMed ID: 16333655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.
    Yamada K; Brink I; Bissé E; Epting T; Engelhardt R
    J Dermatol; 2005 May; 32(5):316-34. PubMed ID: 16043894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
    Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy.
    Engles JM; Quarless SA; Mambo E; Ishimori T; Cho SY; Wahl RL
    J Nucl Med; 2006 Apr; 47(4):603-8. PubMed ID: 16595493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
    Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
    Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
    Song YS; Lee WW; Chung JH; Park SY; Kim YK; Kim SE
    Lung Cancer; 2008 Jul; 61(1):54-60. PubMed ID: 18191496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.
    Tian M; Zhang H; Higuchi T; Oriuchi N; Nakasone Y; Takata K; Nakajima N; Mogi K; Endo K
    Ann Nucl Med; 2005 Jun; 19(4):335-8. PubMed ID: 16097646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
    Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
    Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.
    Khandani AH; Dunphy CH; Meteesatien P; Dufault DL; Ivanovic M; Shea TC
    Nucl Med Commun; 2009 Aug; 30(8):594-601. PubMed ID: 19536037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
    Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.